On Wednesday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: Netlist Inc. (NASDAQ:NLST), Apollo Education Group, Inc. (NASDAQ:APOL), Mad Catz Interactive Inc. (NYSEMKT:MCZ), Amedica Corporation (NASDAQ:AMDA)
Netlist Inc. (NASDAQ:NLST), with shares drowned -49.70%, closed at $0.679, hitting new 52-week low of $0.52.
Apollo Education Group, Inc. (NASDAQ:APOL), with shares dropped -28.40%, settled at $20.04, hitting new 52-week low of $19.82.
Mad Catz Interactive Inc. (NYSEMKT:MCZ), with shares dipped -26.22%, and closed at $0.376.
Amedica Corporation (NASDAQ:AMDA), plummeted -17.78%, and closed at $0.460, hitting new 52-week low of $0.38.
Latest NEWS regarding these Stocks are depicted underneath:
Netlist Inc. (NASDAQ:NLST)
Netlist Inc. (NLST), declared that it will report its financial results for the fourth quarter and full year ended December 27, 2014, at 8:00 a.m. Eastern Time on Friday, March 27, 2015, and will host a conference call at 10:00 a.m. Eastern Time that same day.
Netlist, Inc. designs, manufactures, and sells a range of logic-based memory subsystems for the datacenter, storage, and high-performance computing markets worldwide.
Apollo Education Group, Inc. (NASDAQ:APOL)
Apollo Education Group, Inc. (APOL), stated financial results for the three and six months ended February 28, 2015, with second quarter proceed of $578.6 million and a $0.31 diluted loss per share, or $0.10 loss per share, not including special items.
Second Quarter 2015 Results of Operations:
Apollo Education Group, stated net proceed for the second quarter 2015 of $578.6 million, contrast to $672.8 million for the second quarter 2014. Second quarter 2015 University of Phoenix New Degreed Enrollment was 28,300 and Degreed Enrollment was 213,800. Operating loss for the second quarter 2015 was $54.5 million, contrast to operating revenue of $10.3 million for the second quarter 2014. Loss from ongoing operations attributable to Apollo Education Group for the second quarter 2015 was $33.6 million, or $0.31 per share, contrast to revenue of $16.6 million, or $0.15 per share for the preceding year second quarter.
Not taking into account special items, operating loss was $17.1 million for the second quarter 2015, contrast to operating revenue of $47.5 million for the second quarter 2014, and loss from ongoing operations attributable to Apollo Education Group for the second quarter 2015 was $10.4 million, or $0.10 per share, contrast to revenue of $34.1 million, or $0.30 per share, for the second quarter 2014.
Business Outlook:
The Corporation offers the following outlook for fiscal year 2015 based on the business trends observed during the second quarter of fiscal year 2015, in addition to administration’s current expectations of future trends.
- Net proceed of $2.63 to $2.68 billion; and
- Operating revenue of $200 to $230 million, not including the influence of special items.
The Corporation also provides the following outlook for the third quarter of fiscal year 2015.
- Net proceed of $690 to $705 million; and
- Operating revenue of $85 to $95 million, not including the influence of special items.
Apollo Education Group, Inc. provides private education services. It offers online and on-campus undergraduate, graduate, professional development, and other non-degree educational programs and services primarily to working learners in the United States and internationally. The corporation operates in University of Phoenix, Apollo Global, and Other segments.
Mad Catz Interactive Inc. (NYSEMKT:MCZ)
Mad Catz Interactive Inc. (MCZ), declared that it has reached a securities purchase contract with certain institutional investors to sell 8,980,773 shares of its ordinary stock and warrants to purchase up to 4,490,387 shares of its ordinary stock. The securities will be sold in units at a price of $0.41 per unit, with each unit comprising of one share of ordinary stock and a warrant to purchase 0.5 shares of ordinary stock at an exercise price of $0.61 per whole share. The warrants will be exercisable for a period of five years starting on the six-month anniversary of original issuance and ending on the date that is five years after the initial exercise date. The offering is predictable to result in net proceeds to Mad Catz of about $3.3 million, after deducting the placement agent’s commissions and estimated offering expenses.
The closing of the offering is predictable to occur on or about March 30, 2015, subject to customary closing conditions, at which time Mad Catz will receive the cash proceeds and deliver the securities to the investors.
The principal purpose of the offering is to enhance liquidity, working capital and operational flexibility. Mad Catz may also use a portion of the net proceeds to procure long lead time materials related to the manufacturing of products for the forthcoming launch of the Rock Band 4 video game.
Mad Catz Interactive, Inc. designs, manufactures, markets, sells, and distributes various entertainment products in the United States and internationally. The corporation offers various accessories for in-home gaming consoles, handheld gaming consoles, personal computers, smart phones, tablets, and other mobile devices.
Amedica Corporation (NASDAQ:AMDA)
Formerly on March 5, Amedica Corporation (AMDA), declared financial results for the fourth quarter and full year ended December 31, 2014.
Total product proceed raised by 2% during 2014 to $22.8 million, as contrast to $22.3 million in 2013. This was primarily attributable to a 41% raise, or $3.2 million, in silicon nitride ceramic product proceed over the preceding-year period due to raised market adoption of the Valeo(TM) spinal interbody devices and the Corporation’s focus on its core silicon nitride technology.
Gross profit for the full year 2014 totaled $14.9 million, contrast to $15.3 million in the same period last year. Gross margin percentage for the full year 2014 was 65%, contrast to 68% for the full year 2013. Not including the influence of excess or obsolete inventory for both years, full year 2014 gross margins improved by 3 percentage points to 77%, as contrast to the preceding year period, due to production efficiencies and quality improvements.
Net loss for the full year 2014 was $32.6 million, contrast to $8.3 million in the preceding-year period, primarily as a result of a non-cash stock compensation expense of about $10.2 million, higher operating expenses, raised interest expense, a loss on the extinguishment of debt and offering costs incurred during the year.
Adjusted EBITDA, which is defined as earnings before deductions for interest, taxes, depreciation, amortization, non-cash stock compensation expense, change in fair value of our derivative liabilities, offering costs, and loss on extinguishment of debt for the full year 2014 was ($11.9) million, contrast to ($7.7) million for the full year 2013.
Cash and cash equivalents totaled $18.2 million, while total principal debt obligations were $24.5 million as of December 31, 2014.
Amedica Corporation, a commercial-stage biomaterial corporation, develops, manufactures, and sells a range of medical devices in the United States. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; Valeo stand-alone anterior lumbar intervertebral fusion device; and a line of non-silicon nitride spinal fusion products used by surgeons to promote bone growth and fusion in spinal fusion procedures.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
